UT4

SRS2713520 SAMN08097263 GSM2864759 UT4 9606 Homo sapiens bioproject 419748 PRJNA419748 source_name peripheral blood-derived mast cells treatment Untreated source CD34+ derived cell type peripheral blood-derived mast cells passages >98% FcεRI+ CD117+, 10 weeks genotype WT SRS2713521 SAMN08097264 GSM2864758 UT3 9606 Homo sapiens bioproject 419748 PRJNA419748 source_name peripheral blood-derived mast cells treatment Untreated source CD34+ derived cell type peripheral blood-derived mast cells passages >98% FcεRI+ CD117+, 10 weeks genotype WT SRS2713523 SAMN08097268 GSM2864761 IgE2 9606 Homo sapiens bioproject 419748 PRJNA419748 source_name peripheral blood-derived mast cells treatment Myeloma IgE-treated source CD34+ derived cell type peripheral blood-derived mast cells passages >98% FcεRI+ CD117+, 10 weeks genotype WT SRS2713524 SAMN08097267 GSM2864762 IgE3 9606 Homo sapiens bioproject 419748 PRJNA419748 source_name peripheral blood-derived mast cells treatment Myeloma IgE-treated source CD34+ derived cell type peripheral blood-derived mast cells passages >98% FcεRI+ CD117+, 10 weeks genotype WT SRS2713527 SAMN08097262 GSM2864765 Ag2 9606 Homo sapiens bioproject 419748 PRJNA419748 source_name peripheral blood-derived mast cells treatment Myeloma IgE and anti-IgE treated source CD34+ derived cell type peripheral blood-derived mast cells passages >98% FcεRI+ CD117+, 10 weeks genotype WT SRS2713528 SAMN08097261 GSM2864766 Ag3 9606 Homo sapiens bioproject 419748 PRJNA419748 source_name peripheral blood-derived mast cells treatment Myeloma IgE and anti-IgE treated source CD34+ derived cell type peripheral blood-derived mast cells passages >98% FcεRI+ CD117+, 10 weeks genotype WT SRS2713518 SAMN08097258 GSM2864756 UT1 9606 Homo sapiens bioproject 419748 PRJNA419748 source_name peripheral blood-derived mast cells treatment Untreated source CD34+ derived cell type peripheral blood-derived mast cells passages >98% FcεRI+ CD117+, 10 weeks genotype WT SRS2713519 SAMN08097276 GSM2864757 UT2 9606 Homo sapiens bioproject 419748 PRJNA419748 source_name peripheral blood-derived mast cells treatment Untreated source CD34+ derived cell type peripheral blood-derived mast cells passages >98% FcεRI+ CD117+, 10 weeks genotype WT SRS2713522 SAMN08097269 GSM2864760 IgE1 9606 Homo sapiens bioproject 419748 PRJNA419748 source_name peripheral blood-derived mast cells treatment Myeloma IgE-treated source CD34+ derived cell type peripheral blood-derived mast cells passages >98% FcεRI+ CD117+, 10 weeks genotype WT SRS2713525 SAMN08097266 GSM2864763 IgE4 9606 Homo sapiens bioproject 419748 PRJNA419748 source_name peripheral blood-derived mast cells treatment Myeloma IgE-treated source CD34+ derived cell type peripheral blood-derived mast cells passages >98% FcεRI+ CD117+, 10 weeks genotype WT SRS2713526 SAMN08097265 GSM2864764 Ag1 9606 Homo sapiens bioproject 419748 PRJNA419748 source_name peripheral blood-derived mast cells treatment Myeloma IgE and anti-IgE treated source CD34+ derived cell type peripheral blood-derived mast cells passages >98% FcεRI+ CD117+, 10 weeks genotype WT SRS2713529 SAMN08097260 GSM2864767 Ag4 9606 Homo sapiens bioproject 419748 PRJNA419748 source_name peripheral blood-derived mast cells treatment Myeloma IgE and anti-IgE treated source CD34+ derived cell type peripheral blood-derived mast cells passages >98% FcεRI+ CD117+, 10 weeks genotype WT